FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruce Lyons

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Phenomena

Phosphorylation

Physiology

Co-author Network

Publications

TOP 3
A Bruce Lyons; Stephen J Blake; Kathleen V Doherty
Flow cytometric analysis of cell division by dilution of CFSE and related dyes.
Gabriella K Brown; Alexandre Kreiss; A Bruce Lyons; Gregory M Woods
Natural killer cell mediated cytotoxic responses in the Tasmanian devil.
Deborah White; Verity A Saunders; A Bruce Lyons; Susan Branford; Andrew Grigg; L Bik To; Timothy Hughes
In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruce Lyons (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Bruce Lyons; Stephen J Blake; Kathleen V Doherty
Flow cytometric analysis of cell division by dilution of CFSE and related dyes.
Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.] 2013;Chapter 9():Unit9.11.
2011: Gabriella K Brown; Alexandre Kreiss; A Bruce Lyons; Gregory M Woods
Natural killer cell mediated cytotoxic responses in the Tasmanian devil.
PloS one 2011;6(9):e24475.
2005: Deborah White; Verity A Saunders; A Bruce Lyons; Susan Branford; Andrew Grigg; L Bik To; Timothy Hughes
In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.
Blood 2005;106(7):2520-6.
2005: Andrea L Dewar; Andrew C W Zannettino; Timothy P Hughes; A Bruce Lyons
Inhibition of c-fms by imatinib: expanding the spectrum of treatment.
Cell cycle (Georgetown, Tex.) 2005;4(7):851-3.
2005: Andrea L Dewar; Antony C Cambareri; Andrew C W Zannettino; Bernadette L Miller; Kathleen V Doherty; Timothy P Hughes; A Bruce Lyons
Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.
Blood 2005;105(8):3127-32.
2005: Andrea L Dewar; Kathleen V Doherty; Timothy P Hughes; A Bruce Lyons
Imatinib inhibits the functional capacity of cultured human monocytes.
Immunology and cell biology 2005;83(1):48-56.
2003: Andrea L Dewar; R M Domaschenz; Kathleen V Doherty; Timothy P Hughes; A Bruce Lyons
Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.
Leukemia 2003;17(9):1713-21.
2002: Ray Wilkinson; A Bruce Lyons; Donna Roberts; Mae-Xhum Wong; Paul A Bartley; Denise E Jackson
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease.
Blood 2002;100(1):184-93.
2001: Andrea L Dewar; Kathleen V Doherty; Gregory M Woods; A Bruce Lyons; H Konrad Muller
Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.
Immunology 2001;103(1):61-9.